At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study

por Cepeda, M. Soledad, Kern, David M., Canuso, Carla M.
Publicado 2021

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia

por Turkoz, Ibrahim, Bossie, Cynthia A, Dirks, Bryan, Canuso, Carla M
Publicado 2008

Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension

por Kozma, Chris M, Dirani, Riad G, Canuso, Carla M, Mao, Lian
Publicado 2010

Role of paliperidone extended-release in treatment of schizoaffective disorder

por Canuso, Carla M, Turkoz, Ibrahim, Fu, Dong Jing, Bossie, Cynthia A
Publicado 2010

Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis

por Turkoz, Ibrahim, Bossie, Cynthia A, Lindenmayer, Jean-Pierre, Schooler, Nina, Canuso, Carla M
Publicado 2011

Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray

por Rozjabek, Heather, Li, Nan, Hartmann, Holger, Fu, Dong Jing, Canuso, Carla, Jamieson, Carol
Publicado 2022

Comment to Drs Gastaldon, Papola, Ostuzzi and Barbui

por Mathews, Maju, Daly, Ella J., Popova, Vanina, Heerlein, Kristin, Canuso, Carla, Drevets, Wayne C.
Publicado 2020

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-...

por Chen, Xu, Hou, Xuan, Bai, Daisy, Lane, Rosanne, Zhang, Chong, Canuso, Carla, Wang, Gang, Fu, Dong-Jing
Publicado 2023

Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”

por Borentain, Stephane, Desai, Pooja, Fu, Dong-Jing, Nancy Chen, Li, Lane, Rosanne, Mathews, Maju, Canuso, Carla M
Publicado 2022

Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIR...

por Jamieson, Carol, Canuso, Carla M., Ionescu, Dawn F., Lane, Rosanne, Qiu, Xin, Rozjabek, Heather, Molero, Patricio, Fu, Dong-Jing
Publicado 2023

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

por Fu, Dong-Jing, Turkoz, Ibrahim, Simonson, R. Bruce, Walling, David, Schooler, Nina, Lindenmayer, Jean-Pierre, Canuso, Carla, Alphs, Larry
Publicado 2016

Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials

por Jones, Robyn R., Freeman, Marlene P., Kornstein, Susan G., Cooper, Kimberly, Daly, Ella J., Canuso, Carla M., Nicholson, Susan
Publicado 2022

Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.

por Chen, Guang, Mannens, Geert, De Boeck, Marlies, Daly, Ella J., Canuso, Carla M., Teuns, Greet, Manji, Husseini, Drevets, Wayne C.
Publicado 2022

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major d...

por Kern, David M., Canuso, Carla M., Daly, Ella, Johnson, Jonathan C., Fu, Dong Jing, Doherty, Teodora, Blauer‐Peterson, Cori, Cepeda, M. Soledad
Publicado 2023

Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior

por Canuso, Carla M., Ionescu, Dawn F., Li, Xiang, Qiu, Xin, Lane, Rosanne, Turkoz, Ibrahim, Nash, Abigail I., Lopena, Tricia J., Fu, Dong-Jing
Publicado 2021

Genome-wide association study meta-analysis of suicide death and suicidal behavior

por Li, Qingqin S., Shabalin, Andrey A., DiBlasi, Emily, Gopal, Srihari, Canuso, Carla M., Palotie, Aarno, Drevets, Wayne C., Docherty, Anna R., Coon, Hilary
Publicado 2022

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality

por Fu, Dong-Jing, Zhang, Qiaoyi, Shi, Ling, Borentain, Stephane, Guo, Shien, Mathews, Maju, Anjo, Joana, Nash, Abigail I., O’Hara, Marguerite, Canuso, Carla M.
Publicado 2023

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Dou...

por Ionescu, Dawn F, Fu, Dong-Jing, Qiu, Xin, Lane, Rosanne, Lim, Pilar, Kasper, Siegfried, Hough, David, Drevets, Wayne C, Manji, Husseini, Canuso, Carla M
Publicado 2020